A. S. M. Zadelaar

Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer.

T. V. van Berkel, L. Havekes, M. Versnel, 2005, Atherosclerosis.

Dual PPAR&agr;/&ggr; Agonist Tesaglitazar Reduces Atherosclerosis in Insulin-Resistant and Hypercholesterolemic ApoE*3Leiden Mice

J. Jukema, T. Kooistra, L. Havekes, 2006 .

The Dual PPARα/γ Agonist Tesaglitazar Reduces Atherosclerosis Development Beyond its Plasma Cholesterol-Lowering Effects in APOE*3Leiden Transgenic Mice

J. Jukema, T. Kooistra, G. Camejo, 2006 .

Mdm2 Protects Terminally Differentiated Smooth Muscle Cells from p53-Mediated Cell Death with a Necrotic Morphotype

A. Jochemsen, J. Marine, L. Havekes, 2006 .

Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice

J. Jonkers, L. Havekes, B. Water, 2006 .

Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice.

J. Jukema, T. Kooistra, L. Havekes, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE‐deficient mice

I. van der Made, B. van de Water, J. Jonkers, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.

L. Havekes, B. V. van Vlijmen, M. Gijbels, 2005, Cardiovascular research.

Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice.

A. Jochemsen, B. van de Water, A. Teunisse, 2009, Atherosclerosis.